Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.
Doldi V, Tortoreto M, Colecchia M, Maffezzini M, Percio S, Giammello F, Brandalise F, Gandellini P, Zaffaroni N. Doldi V, et al. Among authors: maffezzini m. J Exp Clin Cancer Res. 2024 Jun 11;43(1):161. doi: 10.1186/s13046-024-03081-0. J Exp Clin Cancer Res. 2024. PMID: 38858661 Free PMC article.
The Immunomodulatory Effects of Fluorescein-Mediated Sonodynamic Treatment Lead to Systemic and Intratumoral Depletion of Myeloid-Derived Suppressor Cells in a Preclinical Malignant Glioma Model.
Pellegatta S, Corradino N, Zingarelli M, Porto E, Gionso M, Berlendis A, Durando G, Maffezzini M, Musio S, Aquino D, DiMeco F, Prada F. Pellegatta S, et al. Among authors: maffezzini m. Cancers (Basel). 2024 Feb 15;16(4):792. doi: 10.3390/cancers16040792. Cancers (Basel). 2024. PMID: 38398183 Free PMC article.
Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.
Anghileri E, Patanè M, Di Ianni N, Sambruni I, Maffezzini M, Milani M, Maddaloni L, Pollo B, Eoli M, Pellegatta S. Anghileri E, et al. Among authors: maffezzini m. Cancers (Basel). 2021 Dec 7;13(24):6156. doi: 10.3390/cancers13246156. Cancers (Basel). 2021. PMID: 34944776 Free PMC article. Review.
Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patients.
Maffezzini M, Fontana V, Pacchetti A, Dotta F, Cerasuolo M, Chiappori D, Guano G, Mantica G, Terrone C. Maffezzini M, et al. Arch Ital Urol Androl. 2021 Mar 18;93(1):15-20. doi: 10.4081/aiua.2021.1.15. Arch Ital Urol Androl. 2021. PMID: 33754602 Free article.
Re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomized Controlled Trial. Eur Urol 2020;78:856-62.
Signorini C, Maffezzini M. Signorini C, et al. Among authors: maffezzini m. Eur Urol. 2021 May;79(5):e135-e136. doi: 10.1016/j.eururo.2021.01.034. Epub 2021 Feb 13. Eur Urol. 2021. PMID: 33593654 No abstract available.
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.
Gacci M, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Greco I, Maggi S, Magrini SM, Mirone V, Montironi R, Morgia G, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Russo G, Salonia A, Simonato A, Serni S, Tomasini D, Tubaro A, Zagonel V, Crepaldi G; MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group. Gacci M, et al. World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1. World J Urol. 2021. PMID: 32740803
124 results